• No results found

Vaginal progesterone

Vaginal progesterone in risk reduction of preterm birth in women with short cervix

Vaginal progesterone in risk reduction of preterm birth in women with short cervix

... receive vaginal progesterone (Group B) compared with those allocated to placebo (Group A) had a significantly lower rate of preterm birth before 28 weeks of gestation ...

6

Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy

Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy

... decreases. Vaginal progesterone, a naturally occurring steroid hormone, is the most bioavailable form of progesterone for uterine and cervical effects with the fewest side ...of vaginal ...

10

Comparison the Effectiveness of Oral Dydrogesterone, Vaginal Progesterone Suppository and Progesterone Ampule for Luteal Phase Support on Pregnancy Rate during ART Cycles

Comparison the Effectiveness of Oral Dydrogesterone, Vaginal Progesterone Suppository and Progesterone Ampule for Luteal Phase Support on Pregnancy Rate during ART Cycles

... with progesterone suppository for luteal phase support ...and vaginal progesterone ...of progesterone including oral dydrogesterone, progesterone gel and micronized progesterone ...

8

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study) : a multicentre, randomised, double blind trial

Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study) : a multicentre, randomised, double blind trial

... Vaginal progesterone administration has been shown to reduce the risk of preterm birth and neonatal morbidity in women at high risk, but there is uncertainty about longer term eff ects on the ...with ...

12

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest®) for luteal phase support during IVF treatment

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest<sup>&reg;</sup>) for luteal phase support during IVF treatment

... with vaginal progesterone tablets compared with intramuscular ...the progesterone tablet applicator for repeated use, as reported by ...of progesterone tablet administration. Even when the ...

11

Role of Vaginal Progesterone in Prevention of Preterm Labor in Women with Previous History of One or More Previous Preterm Births

Role of Vaginal Progesterone in Prevention of Preterm Labor in Women with Previous History of One or More Previous Preterm Births

... mg vaginal progesterone can reduce the incidence of preterm birth in women with do- cumented history of preterm birth <37 weeks of gestation or ...the progesterone 200 mg vaginal ...

9

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk

... or vaginal progesterone therapy ...[35], progesterone supplementation is increas- ingly used as it negates the surgical risks associated with cerclage insertion such as maternal pyrexia, ...

14

Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor

Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor

... additional vaginal progesterone after successful tocolysis with nifedipine resulted in significant prolongation of ...of progesterone in maintaining pregnancy has long been ...recognized. ...

8

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol

... of vaginal progesterone for the prevention of preterm birth among HIV-infected women, this pilot study will allow us to estimate key parameters of trial feasibility: uptake, adherence, and ...prenatal ...

9

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in IVF (in vitro fertilization): A randomized clinical trial

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in IVF (in vitro fertilization): A randomized clinical trial

... Materials and Methods: We performed this prospective, randomized trial in a tertiary infertility care unit in Taleghani Hospital, Tehran, Iran. In total 80 Women with a history of male factor infertility undergoing ...

6

Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy

Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy

... A recent Cochrane meta-analysis discussing luteal phase support for ART cycles confirmed that P has a sig- nificantly positive effect on clinical pregnancy, live birth and on-going pregnancy rates [3].The pharmacological ...

6

Comparing intramuscular progesterone, vaginal progesterone and 17 a-hydroxyprogestrone caproate in IVF and ICSI cycle

Comparing intramuscular progesterone, vaginal progesterone and 17 a-hydroxyprogestrone caproate in IVF and ICSI cycle

... administered progesterone in oil (100mg, IM daily, Pars Minoo, Iran), those in group 2 were given intravaginal progesterone (400mg, twice daily, Cyclogest, Chemist Direct, UK) and group 3 received 17HPC ...

6

The role of progesterone in prevention of preterm birth

The role of progesterone in prevention of preterm birth

... infants. Progesterone has a role in maintaining pregnancy, by suppression of the calcium–calmodulin–myosin light chain kinase ...Additionally, progesterone has recognized anti-inflammatory properties, ...

12

Luteal phase support in assisted reproductive technology treatment: focus on Endometrin&reg; (progesterone) vaginal insert

Luteal phase support in assisted reproductive technology treatment: focus on Endometrin<sup>&reg;</sup> (progesterone) vaginal insert

... of progesterone in the luteal phase and continuance of progesterone therapy during the first trimester has been found in several studies to have benefits in promoting fertility, preventing miscarriages and ...

5

Role of serum progesterone in threatened miscarriage

Role of serum progesterone in threatened miscarriage

... at progesterone assay was ...serum progesterone and USG and followed up to ...serum progesterone of the studied population was significantly high in viable pregnancy group ...serum ...

7

Resection of the vaginal vault for vaginal recurrence of cervical cancer after hysterectomy and brachytherapy

Resection of the vaginal vault for vaginal recurrence of cervical cancer after hysterectomy and brachytherapy

... resection of the vault was performed via laparotomy. Total vaginectomy resulted in complications (grade 3, 37.5%; 3/8) because of the adherence of the bladder and rectum after the first surgery and radiotherapy. Bladder ...

6

Estrogen, Progesterone and Epithelial Ovarian Cancer

Estrogen, Progesterone and Epithelial Ovarian Cancer

... Injectable progestins have been widely used as contracep- tives by women of the third world under the USAID pro- gram [70]. Depot medroxyprogesterone acetate (MPA), marketed under the brand name Depo-Provera, taken every ...

8

The Effect of Extract of Oak Gall for Vaginal Tightening and Rejuvenation in Women with Vaginal Relaxation

The Effect of Extract of Oak Gall for Vaginal Tightening and Rejuvenation in Women with Vaginal Relaxation

... On the other hand, the natural antimicrobial effects of oak extract helps to prevent infection. In elderly women, the thinning of vaginal layers causes dyspareunia, vaginal dryness, redness and increased ...

9

Primary intent vaginal hysterectomy: outcomes for common contraindications to vaginal approach hysterectomy

Primary intent vaginal hysterectomy: outcomes for common contraindications to vaginal approach hysterectomy

... The rate of conversion to abdominal route was higher, operative time longer—though with comparable ranges of 47–331 min vs. 39–332min—and average uterine weight greater in the non-standard as compared to the standard ...

9

The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women

The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women

... minimum progesterone value to exclude data from anovulatory cy- cles from the analyses helped ensure acquisition of the mid-luteal phase samples, only 52% of samples were ob- tained on exactly the 5 th day from ...

11

Show all 1250 documents...

Related subjects